Insulin Injection Aids Market To Reach $ 378.7 Million By 2030

Insulin Injection Aids Market Growth & Trends

The global insulin injection aids market size is anticipated to reach USD 378.7 million by 2030, growing at a CAGR of from 2024 to 2030, according to a new report by Grand View Research, Inc. A major factor propelling the market for insulin injection aids is the rising prevalence of diabetes. Furthermore, increasing preference for advanced insulin administration methods over conventional vials and syringes, such as insulin pumps, injectors, and pens is fueling the market.

Growing prevalence of diabetes is leading to the higher demand for the insulin injection aids. For instance, according to the report published by IDF Diabetes Atlas, in 2022, 537 Million adults had diabetes - 1 in 10. This number is expected to rise to 634 Million by 2030 and 783 Million by 2045. The availability of insulin injection aids makes it easier to administer insulin precisely and conveniently, which helps with better diabetes care.

Additionally, technological advancements are another factor driving the growth of the market. Technological advancements have enabled the creation of more advanced and user-friendly insulin delivery systems. To enhance the entire experience for individuals with diabetes, technological advancements have had a considerable impact on the development of insulin injection aids. For instance, syringe magnifiers are developed for the people with poor vision, the markings and number on the syringe are enlarged with this device to help the patients read the dosage requirements on the syringe. Moreover, I-Port Injection Port developed by Medtronic plc is a port that should be worn for up to three days on the skin to avoid skin puncture at every insulin dose. Additionally, syringe filling devices, injectors such as pen or auto injectors are designed to help people for better diabetes management.

 Request a free sample copy or view report summary: Insulin Injection Aids Market Report

Insulin Injection Aids Market Report Highlights

• Based on products, syringe aids segment dominated the market in 2023, with a share of 38.77% owing to the rising prevalence of diabetes

• Based on end-use, home care settings segment dominated the market with a share of 45.36% in 2023. The convenience, individualized treatments, and potential cost savings contributed to its largest market share.

• North America led the market with the maximum revenue share in 2023, owing to the increasing number of patients suffering from diabetes.

Insulin Injection Aids Market Segmentation 

Grand View Research has segmented the global insulin injection aids market based on product, end-use and regions:

Insulin Injection Aids Product Outlook (Revenue, USD Million, 2018 - 2030)

• Insulin Vial Aids

• Syringe Aids

• Injectors

• Aids for Kids

• Others

Insulin Injection Aids End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Specialty Clinics

• Home Care Settings

• Others

Insulin Injection Aids Regional Outlook (USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Insulin Injection Aids Market 

• Medtronic Plc

• Convatec Inc.

• Becton, Dickinson and Co.

• AmbiMedInc.

• Medicool

• TickleTec Ltd

• Pain Care Labs

• Apothecary Products

• BIONIX LLC

• Prodigy Diabetes Care, LLC